Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5

Eric D. Young, Sharon J. Manley, Thomas C. Beadnell, Alexander E. Shearin, Ken Sasaki, Rosalyn Zimmerman, Evan Kauffman, Carolyn J. Vivian, Aishwarya Parasuram, Tomoo Iwakuma, Paul M. Grandgenett, Michael A. Hollingsworth, Maura O’Neil, Danny R. Welch

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: Previously, we identified ITIH5 as a suppressor of pancreatic ductal adenocarcinoma (PDAC) metastasis in experimental models. Expression of ITIH5 correlated with decreased cell motility, invasion and metastasis without significant inhibition of primary tumour growth. Here, we tested whether secretion of ITIH5 is required to suppress liver metastasis and sought to understand the role of ITIH5 in human PDAC. Methods: We expressed mutant ITIH5 with deletion of the N-terminal secretion sequence (ITIH5Δs) in highly metastatic human PDAC cell lines. We used a human tissue microarray (TMA) to compare ITIH5 levels in uninvolved pancreas, primary and metastatic PDAC. Results: Secretion-deficient ITIH5Δs was sufficient to suppress liver metastasis. Similar to secreted ITIH5, expression of ITIH5Δs was associated with rounded cell morphology, reduced cell motility and reduction of liver metastasis. Expression of ITIH5 is low in both human primary PDAC and matched metastases. Conclusions: Metastasis suppression by ITIH5 may be mediated by an intracellular mechanism. In human PDAC, loss of ITIH5 may be an early event and ITIH5-low PDAC cells in primary tumours may be selected for liver metastasis. Further defining the ITIH5-mediated pathway in PDAC could establish future therapeutic exploitation of this biology and reduce morbidity and mortality associated with PDAC metastasis.

Original languageEnglish (US)
Pages (from-to)166-175
Number of pages10
JournalBritish journal of cancer
Volume124
Issue number1
DOIs
StatePublished - Jan 5 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5'. Together they form a unique fingerprint.

Cite this